Therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: Biology, clinical results and future development

Brian I. Rini; Jeffrey A. Sosman; Robert J. Motzer

doi:10.1111/j.1464-410X.2005.05616.x

Therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: Biology, clinical results and future development

Brian I. Rini^*, Jeffrey A. Sosman, Robert J. Motzer

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Review article › peer-review

52 Scopus citations

Original language	English (US)
Pages (from-to)	286-290
Number of pages	5
Journal	BJU International
Volume	96
Issue number	3
DOIs	https://doi.org/10.1111/j.1464-410X.2005.05616.x
State	Published - Aug 2005

Keywords

BAY 43-9006
Bevacizumab
RCC
SU11248
VEGF
VHL

ASJC Scopus subject areas

Urology

Access to Document

10.1111/j.1464-410X.2005.05616.x

Cite this

@article{0eafd07595d644d5abdb0078031878ac,

title = "Therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: Biology, clinical results and future development",

keywords = "BAY 43-9006, Bevacizumab, RCC, SU11248, VEGF, VHL",

author = "Rini, {Brian I.} and Sosman, {Jeffrey A.} and Motzer, {Robert J.}",

year = "2005",

month = aug,

doi = "10.1111/j.1464-410X.2005.05616.x",

language = "English (US)",

volume = "96",

pages = "286--290",

journal = "BJU International",

issn = "1464-4096",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

TY - JOUR

T1 - Therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma

T2 - Biology, clinical results and future development

AU - Rini, Brian I.

AU - Sosman, Jeffrey A.

AU - Motzer, Robert J.

PY - 2005/8

Y1 - 2005/8

KW - BAY 43-9006

KW - Bevacizumab

KW - RCC

KW - SU11248

KW - VEGF

KW - VHL

UR - http://www.scopus.com/inward/record.url?scp=23244458246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23244458246&partnerID=8YFLogxK

U2 - 10.1111/j.1464-410X.2005.05616.x

DO - 10.1111/j.1464-410X.2005.05616.x

M3 - Review article

C2 - 16042715

AN - SCOPUS:23244458246

SN - 1464-4096

VL - 96

SP - 286

EP - 290

JO - BJU International

JF - BJU International

IS - 3

ER -

Therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: Biology, clinical results and future development

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this